HMGB1 mediates the effect of TMZ in inducing the formation of GSCs via TLR2/NEAT1/Wnt/β-catenin signaling, thus might promote the resistance to TMZ in GBM patients. This evidence concerns the gene HMGB1 and glioblastoma.